132 related articles for article (PubMed ID: 24843717)
1. Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.
Fujiwara D; Takahashi K; Suzuki T; Shii M; Nakashima Y; Takekawa S; Yoshida A; Matsuoka T
J Diabetes Investig; 2013 Nov; 4(6):618-25. PubMed ID: 24843717
[TBL] [Abstract][Full Text] [Related]
2. A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy.
Suzuki T; Takahashi K; Fujiwara D; Shii M; Takekawa S; Matsuoka T
Diabetol Int; 2016 Sep; 7(3):235-243. PubMed ID: 30603269
[TBL] [Abstract][Full Text] [Related]
3. Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.
Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Takahara S; Nagashima K; Hosokawa M; Seino Y; Inagaki N
J Diabetes Investig; 2011 Aug; 2(4):297-303. PubMed ID: 24843502
[TBL] [Abstract][Full Text] [Related]
4. [Indicators for insulin therapy in late elderly patients with type 2 diabetes mellitus--the relationship between plasma C-peptide on glucagon load test and insulin therapy].
Miyamoto M
Nihon Ronen Igakkai Zasshi; 2009 May; 46(3):244-9. PubMed ID: 19521045
[TBL] [Abstract][Full Text] [Related]
5. Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: a long-term follow-up study.
Fukui T; Oono K; Hara N; Yamamoto T; Nagashima M; Naito H; Hirano T
Endocr J; 2013; 60(6):715-24. PubMed ID: 23386398
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
Okuno Y; Sakaguchi K; Komada H; Hashimoto N; Hirota Y; Nakamura T; Ogawa W; Seino S
Kobe J Med Sci; 2013 Apr; 59(2):E44-53. PubMed ID: 23756662
[TBL] [Abstract][Full Text] [Related]
7. Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.
Lee SW; Lee S; Kim SH; Kim TH; Kang BS; Yoo SH; Lee MK; Koh WJ; Kang WS; Kim HJ
Yonsei Med J; 2011 Nov; 52(6):939-47. PubMed ID: 22028157
[TBL] [Abstract][Full Text] [Related]
8. Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.
Iwata M; Matsushita Y; Fukuda K; Wakura T; Okabe K; Koshimizu Y; Fukushima Y; Kobashi C; Yamazaki Y; Honoki H; Suzuki H; Kigawa M; Tobe K
J Diabetes Investig; 2014 Sep; 5(5):570-80. PubMed ID: 25411626
[TBL] [Abstract][Full Text] [Related]
9. Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients.
Enkaku A; Chujo D; Kamigishi M; Inagawa S; Matsukoshi S; Sakai W; Takikawa A; Fujisaka S; Tobe K
J Diabetes Investig; 2024 Apr; 15(4):437-448. PubMed ID: 38151917
[TBL] [Abstract][Full Text] [Related]
10. Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.
Ogiso K; Koriyama N; Obo T; Tokito A; Nishio Y
Diabetol Int; 2021 Apr; 12(2):161-170. PubMed ID: 33786271
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with long-term oral hypoglycemic agent responsiveness in korean patients with type 2 diabetes mellitus.
Kim BY; Jung CH; Mok JO; Kim CH
Diabetes Metab J; 2011 Jun; 35(3):282-9. PubMed ID: 21785749
[TBL] [Abstract][Full Text] [Related]
12. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity.
Kozawa J; Inoue K; Iwamoto R; Kurashiki Y; Okauchi Y; Kashine S; Kitamura T; Maeda N; Okita K; Iwahashi H; Funahashi T; Imagawa A; Shimomura I
J Diabetes Investig; 2012 Jun; 3(3):294-7. PubMed ID: 24843579
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.
Shimodaira M; Muroya Y; Kumagai N; Tsuzawa K; Honda K
J Endocrinol Invest; 2013 Oct; 36(9):734-8. PubMed ID: 23580083
[TBL] [Abstract][Full Text] [Related]
15. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
Fujioka Y; Okura T; Sumi K; Matsumoto K; Shoji K; Nakamura R; Matsuzawa K; Izawa S; Kato M; Taniguchi S; Yamamoto K
J Diabetes Investig; 2018 Mar; 9(2):274-278. PubMed ID: 28494143
[TBL] [Abstract][Full Text] [Related]
16. Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.
Iwamoto Y; Kimura T; Tatsumi F; Sugisaki T; Kubo M; Nakao E; Dan K; Wamata R; Iwamoto H; Takahashi K; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nakanishi S; Mune T; Kaku K; Kaneto H
Front Endocrinol (Lausanne); 2022; 13():871660. PubMed ID: 35574023
[TBL] [Abstract][Full Text] [Related]
17. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.
Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Hamamoto Y; Hosokawa M; Seino Y; Inagaki N
Diabetes Res Clin Pract; 2008 Dec; 82(3):353-8. PubMed ID: 18950889
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
[TBL] [Abstract][Full Text] [Related]
19. Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation.
Hiratsuka I; Suzuki A; Kondo-Ando M; Hirai H; Maeda Y; Sekiguchi-Ueda S; Shibata M; Takayanagi T; Makino M; Fukami N; Itoh T; Sasaki H; Kusaka M; Kenmochi T; Hoshinaga K; Itoh M
Transplant Proc; 2014 Apr; 46(3):967-9. PubMed ID: 24767392
[TBL] [Abstract][Full Text] [Related]
20. Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment.
Araki H; Tanaka Y; Yoshida S; Morita Y; Kume S; Isshiki K; Araki S; Uzu T; Kashiwagi A; Maegawa H
J Diabetes Investig; 2014 Jul; 5(4):435-41. PubMed ID: 25411603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
